IOVANCE BIOTHERAPEUTICS, INC. - 8-K Filing

Iovance Biotherapeutics updated its corporate presentation for investor and healthcare conference use on October 5, 2026. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $IOVA

Read the full article at SEC EDGAR

More Regulatory news